The origins and developmental mechanisms of coronary arteries are incompletely understood. We show here by fate mapping, clonal analysis, and immunohistochemistry that endocardial cells generate the endothelium of coronary arteries. Dye tracking, live imaging, and tissue transplantation also revealed that ventricular endocardial cells are not terminally differentiated; instead, they are angiogenic and form coronary endothelial networks. Myocardial Vegf-a or endocardial Vegfr-2 deletion inhibited coronary angiogenesis and arterial formation by ventricular endocardial cells. In contrast, lineage and knockout studies showed that endocardial cells make a small contribution to the coronary veins, the formation of which is independent of myocardialto-endocardial Vegf signaling. Thus, contrary to the current view of a common source for the coronary vessels, our findings indicate that the coronary arteries and veins have distinct origins and are formed by different mechanisms. This information may help develop better cell therapies for coronary artery disease.
INTRODUCTION
Despite the medical importance of coronary arteries, their embryonic origins and developmental mechanisms remain unclear. These arteries are the loci for coronary artery disease, the most widespread disease in western societies.
Elucidating mechanisms of coronary artery formation may help recapitulate this developmental process for coronary artery regeneration.
Coronary arteries have three tissue layers: the inner layer of endothelium, the middle layer of smooth muscle cells, and the outer layer of fibroblasts. The endothelium is the first layer formed during coronary artery formation. Primitive coronary vessels (or coronary plexuses) consist of one endothelial cell layer. The plexuses then recruit smooth muscle cells and fibroblasts to assemble mature arteries. Endothelium is also the first site where coronary artery disease occurs in adults. Thus, identifying the cellular origins of coronary endothelium is essential to elucidate mechanisms of coronary artery development or regeneration.
The heart is made of three major tissue layers: the endocardium, myocardium, and epicardium. The myocardium is the central layer, and the coronary vasculature forms within this layer during development. The epicardium is the outermost epithelial layer of the heart; it is derived from the proepicardium outside the heart (Komiyama et al., 1987; Virá gh and Challice, 1981) . Studies have shown that epicardial cells generate coronary vascular smooth muscle cells (Cai et al., 2008; Dettman et al., 1998; Mikawa and Gourdie, 1996; Vrancken Peeters et al., 1999; Zhou et al., 2008) . It is less clear whether proepicardial/epicardial cells make any significant contribution to coronary endothelial cells, although some coronary endothelial cells in avian species are derived from proepicardial cells Pé rez-Pomares et al., 2002) . Fate-mapping studies in mice have suggested the sinus venosus as a common origin of the endothelium of coronary arteries and veins (Red-Horse et al., 2010) , and a subset of proepicardial cells also contributes to some coronary endothelial cells (Katz et al., 2012 ).
The endocardium is the internal epithelial layer of the heart. Endocardial cells are one of the earliest endothelial populations acquired in development, differentiating from multipotent progenitors in the cardiac field (Misfeldt et al., 2009; Sugi and Markwald, 1996; Yamashita et al., 2000; Yang et al., 2008) . They form an endocardial tube by vasculogenesis and later become the endocardium of the heart (Drake and Fleming, 2000) . Endothelial cells of coronary vessels arise later in development and form coronary vessels in the myocardium (Lavine and Ornitz, 2009; Luttun and Carmeliet, 2003; Majesky, 2004; Olivey and Svensson, 2010; Wada et al., 2003) . Ventricular endocardial cells have been thought to be terminally differentiated without a significant role in coronary vessel formation.
Here, we showed that ventricular endocardial cells are a major origin of coronary artery endothelium. Myocardial Vegf-a to endocardial Vegfr-2 signaling is required for these cells to differentiate into coronary endothelium. The information may have implications for engineering better vessels for coronary artery regeneration.
RESULTS

Characterization of Nfatc1 Expression during Coronary Vessel Development
Cardiac endocardial cells comprise a unique endothelial cell population that expresses Nfatc1 during development, whereas vascular endothelial cells do not express Nfatc1 (Chang et al., 2004; de la Pompa et al., 1998; Ranger et al., 1998; Zhou et al., 2005) . In this study, we further characterized Nfatc1 expression in embryonic tissues relative to coronary development. We confirmed by in situ hybridization that Nfatc1 transcripts demarcated endocardium at embryonic day (E) 9.5, since the endothelium of aortic sac, sinus venosus, and the rest of the peripheral vasculature was negative for Nfatc1 transcripts (Figures 1A and 1B) . Nfatc1 transcripts were not found in the proepicardium either. At E10.5 Nfatc1 transcripts were similarly restricted to the endocardium ( Figure 1C ). Likewise, double immunostaining of Nfatc1 and Pecam1 (pan-endothelial marker) revealed that Nfatc1 proteins were confined to the endocardium ( Figure 1D ). Neither Nfatc1 transcripts nor proteins were detected in the forming epicardium. Furthermore, coimmunostaining of Nfatc1 and Tbx18 (epicardial marker) (Kraus et al., 2001) confirmed that epicardial cells did not express Nfatc1 at E11.5 ( Figure 1E ).
When coronary plexuses developed from E11.5 to E13.5, Nfatc1 transcripts were downregulated in the ventricular endocardium (data not shown) while Nfatc1 proteins remained in a subset of endocardial cells ( Figures 1F-1H ). Neither Nfatc1 transcripts (data not shown) nor Nfatc1 proteins were found in the endothelium of coronary plexuses ( Figures 1G and 1H) . Likewise, the endothelium of developed coronary vessels from E14.5 to E16.5 did not have detectable Nfatc1 transcripts or Nfatc1 proteins, which were found only in the valve endocardium (Figures S1A-S1F available online; Supplemental Information). These findings showed that Nfatc1 expression is restricted to the endocardium during coronary development. Nfatc1 is not expressed in the proepicardium/epicardium, sinus venosus, or developing coronary vessels.
Nfatc1
+ Endocardial Precursors Generate Coronary
Plexuses
To study the developmental fate and function of endocardial cells, we generated a Cre knockin mouse strain, Nfatc1
Cre , in which Cre cDNA with an internal ribosomal entry site was inserted downstream of the stop codon of the mouse Nfatc1 (Zhou et al., 2002) (Figure S2A ). Nfatc1
Cre mice developed normally and bred to the RCE fsEGFP (Miyoshi et al., 2010; Sousa et al., 2009) or R26 fslz mice (Soriano, 1999) . Cre expression was restricted to the endocardium of Nfatc1 Cre embryos; no expression was seen in the sinus venosus, liver, pharyngeal arch, proepicardium/epicardium, or myocardium at E9.5-E10.5 ( Figure S2B ), or developing coronary vessels (data not shown). Figures S2C-S2G ). Although Nfatc1 expression was not found in the sinus venous endothelium ( Figure S2H ), Nfatc1
Cre -mediated b-gal or EGFP expression was observed in some sinus venous endothelial cells at E10.5-E11.5 ( Figures S2I-S2J ), suggesting that Nfatc1 + endocardial cells contribute to a subset of sinus venous endothelial population.
We then examined the lineage contribution of endocardial cells to coronary vessels in Nfatc1
Cre ;R26 fslz embryos and found that cells of the emerging coronary plexuses at E11.5-E13.5 uniformly expressed b-gal (Figure 2 ). The b-gal + cells, derived from the Nfatc1 + precursors at E11.5 (Figure 2A ), invaded the myocardium at E12.5 ( Figure 2B ) and formed coronary plexuses throughout the myocardium at E13.5 ( Figure 2C ). Conversely, in control Nfatc1 lacZ -BAC embryos that expressed b-gal driven by the Nfatc1 promoter/enhancer (Misfeldt et al., 2009 ), b-gal expression (an indicator of the Nfatc1 Cre activities) was restricted to the endocardium and absent in coronary plexuses ( Figures  2D-2F ). This observation is consistent with the finding that coronary plexuses do not express Nfatc1 at these stages, thus further eliminating the possibility of ectopic Cre expression in coronary plexuses.
To verify the cell identity of the endocardial-derived coronary cells, we colabeled the EGFP + descendants of Nfatc1 + endocardial cells with Pecam1 antibodies in Nfatc1
Cre ;RCE fsEGFP embryos. We found that most Pecam1-positive cells in the peritruncal coronary vessels expressed EGFP at E12.5, whereas the vessels outside the heart were labeled only by Pecam1 antibodies ( Figures 2G-2I ). Also, all coronary plexuses arising at E11.5-E13.5 in the ventricular wall coexpressed Pecam1 and EGFP ( Figures S2K-S2M ). We then stained E14.5 or E16.5 Nfatc1
Cre
;RCE fsEGFP heart sections with multiple cardiovascular markers ( Table S1 ) and found that the EGFP + descendants of Nfatc1 + endocardial cells were present in the endothelium of coronary arteries expressing arterial endothelial markers Dll4 ( Figures 2J and S2N ), Ephb2, and Jagged1 (data not shown). We also noted that, although endocardial cells were negative for von Willebrand factor (vWF), their descendants in coronary arteries acquired vWF expression ( Figure 2K ). Thus, the acquisition of vWF and loss of Nfatc1 expression in coronary endothelial cells may serve as makers for endocardial to coronary endothelial differentiation. Further staining of smooth muscle myosin (D) E10.5 heart sections coimmunostained with antibodies against Nfatc1 (brown nuclear staining) and Pecam1 (red membrane staining) show Nfatc1 proteins in the endocardium (arrows) but not epicardium (arrowheads).
(E) E11.5 heart sections show Nfatc1 proteins in the endocardium (arrows) but not in the Tbx18-positive epicardium (arrowheads).
(F-H) E11.5-E13.5 heart sections stained with antibodies against Nfatc1 and Pecam1 show that Nfatc1 proteins are restricted to the endocardium (arrows). They are not present in the endothelium of coronary plexuses or Pecam1-positive cells in the myocardium (myo, arrowheads) or the mature coronary vessels. Dashed line separates the trabeculae from the compact wall. ep, epicardium. Scale bars, 25 mm. See also Figure S1 . heavy chain (SM-MHC) and SM22a showed that the EGFP + endocardial descendants contributed to the endothelium of developed coronary arteries, but they did not become vascular smooth muscle cells of the cognate vessels (Figures 2L and 2M) . In contrast to their prominent arterial presence, few EGFP + descendants of endocardial cells were found in coronary veins ( Figure S2O ). EGFP + descendants were also absent in lymphatic vessels ( Figure S2P ) and did not become cardiomyocytes ( Figure S2Q ). We further compared the fate mapping of Nfatc1 Cre -marked endocardial cells in coronary vessels to that of Tie1 Cre -labeled pan-endothelial (arterial and venous) cells (Gustafsson et al., 2001 the coronary vessels of E16.5 hearts showed that they contributed to 72%, 81%, or 37% endothelial population of major coronary arteries, intramyocardial, or subepicardial vessels, respectively ( Figure S2Z ). These findings establish that endocardial cells are a major source of endothelial cells of the intramyocardial vessels including major coronary arteries and suggest that the majority of subepicardial vascular endothelium arises from a different origin.
Clonal Analysis Establishes Spatiotemporal Differentiation of Endocardial Cells into Coronary Endothelial Cells
To confirm that the endocardium is a major source of coronary arterial endothelial cells and determine when endocardial cells are committed to a coronary endothelial fate, we generated Nfatc1 nrtTA -BAC mice using an Nfatc1-BAC DNA (Figures S3A
and S3B) and bred them with tetO-Cre;RCE fsEGFP or tetOCre;R26 fslz mice. When induced with doxycycline (Dox) at E7.5-E11.5, the tetO-Cre-mediated EGFP expression was found to mark endocardial cells and their mesenchymal descendants ( Figures S3C-S3F) . A limited Dox dose was then applied for 24 hr, at E9.5, E10.5, E11.5, or E12.5 ( Figure 3A ), to induce rare recombination events in individual cells in the endocardium ( Figure 3B ). The expansion of EGFP + or b-gal + single cells were chased for 1-7 days until E14.5 or E16.5, and the clonality and coronary location of cell clusters were determined by expression of the reporters, vascular markers, and histology. We analyzed 39 whole hearts by evaluating serial sections (Table S2 ; Figures  3C-3H ). Single or separated EGFP + or b-gal + cell clusters were found in the endothelium of major or small coronary arteries ( Figures 3C-3E ), veins ( Figure 3F ), or capillaries ( Figures 3G  and 3H ). Some cells near developing arteries exhibited filopodia ( Figure S3G ), suggesting that they were migrating cells. Cell clusters were also found in heart valves ( Figures S3H and S3I ). However, they were not detected in the sinus venosus. Quantitative analysis of clones showed that over 86% of the Nfatc1 + endothelial descendants that derived at E9.5-E13.5
were in the intramyocardial vessels at E14.5 or E16.5; the remainders were in the subepicardial vessels ( Figures S4A and  S4B ). The endocardial precursors labeled around E11.5 generated most coronary endothelial cells; their ability to differentiate into endothelial cells was greatly reduced after E12.5. Consistent with their predominant presence in the endothelium of intramyocardial vessels, the number of Nfatc1 + endothelial descendants found in the main coronary arteries at E14.5 or E16.5 was 13 or 5 times greater than that in the main veins ( Figure S4C ). Furthermore, the numbers of labeled endocardial cells across the 39 analyzed hearts correlated significantly with the numbers of their sister endothelial cells in both intramyocardial and subepicardial vessels. However, the correlation between the endocardial and intramyocardial numbers (Pearson's correlation coefficient r = 0.86, p = 4.0 3 10 À12 ) was higher than that between the endocardial and subepicardial numbers (r = 0.59, p = 8.2 3 10 À5 ) ( Figure S4D ). Thus, clonal analysis suggests that endocardial cells commit to a coronary endothelial fate right before coronary plexus formation and supports the conclusion from the Nfatc1 Cre fate mapping that the endocardium is a major source of the endothelium of intramyocardial vessels and major coronary arteries.
Ventricular Endocardial Cells Form Coronary Plexuses by Angiogenesis
To visualize how ventricular endocardial cells generated coronary plexuses, we isolated hearts from E10.5 or E11.5 embryos and labeled endocardial cells with Red Fluorescent CMTPX. The ventricles were used in a Matrigel endothelial tube assay. We found single-labeled endocardial cells that had migrated through the myocardial wall into Matrigel in the presence of Vegf120 ( Figures S5A-S5C Figures 4A-4C ). The angiogenic function of endocardial cells was further characterized by time-lapse fluorescence live imaging and quantified. Without Vegf120, Nfatc1 + precursors invaded the ventricular wall and sprouted to form endothelial tubes, which then fused into distinct vessels in the myocardium (Movie S1). With Vegf120, the Nfatc1 + precursors readily migrated through the ventricular wall (Movie S2) and underwent angiogenic sprouting ( Figures 4D and 4E ). Within 6 days of Vegf120 exposure, the descendants of Nfatc1 + precursors generated sophisticated endothelial networks ( Figures 4G and 4H ). In contrast, angiogenic sprouting and networking were significantly limited without Vegf120 (Figures 4F and 4I ). Besides Vegf120, other Vegf-a isoforms such as Vegf164 and Vegf188 were capable of promoting coronary angiogenesis, whereas Vegf-c, Vegf-d, Fgf2, and Fgf9 had partial or no effects (data not shown). These data showed that endocardial cells can develop into coronary endothelial networks and suggested that Vegf-a is a major factor involved in coronary plexus formation by ventricular endocardial cells.
To further test coronary angiogenesis by ventricular endocardial cells, we conducted quail-to-chick transplantation experiments in which we isolated ventricular endocardium or (J-L) Images of QH1 antibody stained HH34 quail-chick chimerical heart sliced through the right ventricle at the implanted site show that the QH1+ descendants of engrafted HH15 quail endocardial cells invade chick myocardium and generate intramyocardial vessels. Quail endocardial cells, implanted at the surface of the atrioventricular junction of the chick heart (K), generate intensive myocardial vascular networks by angiogenic sprouting and branching (L, arrowheads). See also Figure S5 and Table S3. proepicardium from quail embryonic hearts at the Hamburger and Hamilton (HH) stage 15 (prior to coronary plexus formation) and implanted them at the inner curvature of the atrioventricular junction of HH15 chick embryonic hearts ( Figure S5D ). Using the QH1 antibody that labels quail, but not host chick, endothelial cells, we detected the contribution of implanted quail cells to coronary arteries of chick hearts at HH34 (Figures S5E and  S5F ). Quail endocardial cells invaded chick ventricular wall and developed into an extensive endothelial network in the myocardium ( Figures 4J-4L ), whereas quail proepicardium largely generated subepicardial vessels (Table S3 ; data not shown). Together, the results from four distinct experimental approaches (Nfatc1
Cre fate mapping, clonal analysis, dye labeling, and cross-species transplantation) all demonstrate that ventricular endocardial cells generate endothelial cells of coronary arteries. The endocardial descendants comprise the majority of endothelial cells in intramyocardial vessels and coronary arteries. They further show that endocardial cells are not terminally differentiated; they are angiogenic and are activated by Vegf-a to generate coronary plexuses.
Myocardial Vegf-a Is Required for Coronary Angiogenesis and Artery Formation
Vegf-a is known to be produced by the developing myocardium (Giordano et al., 2001; Miquerol et al., 2000; Tomanek et al., 2006) and required for vasculogenesis and angiogenesis in development (Carmeliet et al., 1996; Ferrara et al., 1996) . Therefore, we asked if myocardial Vegf-a was necessary in vivo for endocardial cells to differentiate into coronary endothelial cells and form coronary arteries. We used the Tnnt2 promoter-Cre (Tnnt2 Cre ) (Chen et al., 2006; Jiao et al., 2003) and Vegf-a f/f mice (Gerber et al., 1999) (Vegf-a-null) hearts showed that angiogenic sprouts or coronary plexuses were present in the peritruncal area or ventricular septum of control ( Figures 5A-5D ) but not Vegf-a-null hearts ( Figures 5E-5H ). Thus, myocardial Vegf-a is necessary for coronary plexus formation. From E12.5 to E13.5 when coronary plexuses had developed into a well-organized intramyocardial endothelial network in control hearts ( Figures S6A and S6C) , the angiogenic defect persisted in all Vegf-a-null hearts leading to myocardial necrosis ( Figures S6B and S6D) . By E14.5, when control hearts developed intramyocardial coronary arteries and subepicardial veins with distinct patterns (Figures 5I-5K ), Vegf-a-null hearts had only a few immature myocardial coronary arteries and developed dilated subepicardial veins ( Figures 5L-5N ). Quantitative analysis confirmed an 88% reduction in the number of Pecam1 + intramyocardial endothelial cells in E14.5 Vegf-a-null hearts, but only a 37% decrease in the subepicardial endothelial cells ( Figure S5E ). These findings indicated that myocardial Vegf-a triggers coronary angiogenesis and is required for arterial formation. The fact that coronary veins formed indicated that they have an embryonic origin independent of myocardial Vegf-a, although the vein defect might be a consequence of myocardial Vegf-a deficiency and/or they might be secondary to the arterial defect.
Vegf-a-null hearts also exhibited cardiac phenotypes, including thin ventricular walls, necrotic septa, cardiac hemorrhages ( Figures S6G and S6I) , and ruptured septa at E15.5 ( Figure S6K ). All Vegf-a-null embryos were runted and died after E15.5 (Table S4 ). To rule out early myocardial defects that might affect coronary angiogenesis, we examined myocardial function and structure but found no myocardial apoptosis, abnormal cardiac gene expression, and alterations in the ultrastructure of sarcomeres, mitochondria, or Golgi apparatus in E11.5-E12.5 Vegfa-null hearts (data not shown). These results suggest that the cardiac phenotypes are a result of the vascular defects.
Endocardial Vegfr-2 Is Required for Coronary Angiogenesis and Artery Formation Vegfr-2 is a major Vegf receptor required for vessel formation during development (Shalaby et al., 1995 Cre embryos (Vegfr-2-null) showed that the deletion was restricted to the endocardium ( Figure S7 , A versus A 0 ), whereas Vegfr-2 expression in the vasculature outside the heart was not affected (Figures S7B-S7E versus S7B 0 -S7E 0 ). Similar to E12.5, Vegf-a-null embryos, E12.5 Vegfr-2-null embryos did not develop coronary plexuses in the peritruncal/coronary sulcus area or ventricular septum (Figures 6A and 6B versus 6C and 6D) . The early angiogenic defect resulted in severely diminished or no coronary arteries in all E14.5 Vegfr-2-null embryos ( Figure 6E versus 6H) . In contrast, coronary veins developed in these embryos ( Figure 6F versus 6I). The arterial specific defect was consistent with Vegfr-2 deletion in the Nfatc1 + endocardial precursors, as Vegfr-2 expression in the endothelium of coronary veins was not affected ( Figure 6G versus 6J) .
Like Vegf-a-null embryos, all Vegfr-2-null embryos developed cardiac hemorrhages at E14.5-E16.5 (Figures S7F and S7H versus SG and SI) , they were runted thereafter and died in utero (Table S5 ). Quantitative analysis of immunostaining confirmed a 74% reduction in the number of Pecam1 + intramyocardial endothelial cells in E14.5 Vegfr-2-null hearts and only a 24% decrease in subepicardial endothelial cells (Figures S7J-S7N ). These results demonstrate that Vegfr-2 function is necessary for differentiation of endocardial cells into endothelial cells to form coronary arteries.
To Figures S7U and S7V) . Thus, these results again indicated that the initial coronary arteries arise from the Nfatc1 + precursors in the endocardium and that Vegf signaling is important for this process. Taken together, the data from the studies of Vegf-a and Vegfr-2-null hearts demonstrate that myocardially produced Vegf-a signals through endocardial Vegfr-2 to stimulate ventricular endocardial cells to undergo angiogenesis that generates coronary arteries. They provide a fifth, independently derived line of functional evidence that endocardial cells are the progenitors of coronary arteries, whereas the endothelium of coronary veins has a different origin. Cre ;Vegf-a f/f (Vegf-a-null) heart show no plexus formation in the peritruncal and septal myocardium.
(I-K) Pictures of E14.5 control heart show the Pecam1+ coronary arteries (ca, arrows) and subepicardial vessels (arrowheads).
(L-N) Pictures of E14.5 Vegf-a-null heart show less and immaturely formed coronary arteries (arrows) but numerous and dilated subepicardial vessels (arrowheads). The null heart also has necrotic peritruncal and septal myocardium (L, arrows). Scale bars for (I) and (L), 100 mm; for all other panels, 20 mm. See also Figure S6 and Table S4 . Table S5 .
DISCUSSION
These studies demonstrated that the endocardium is a major source of endothelial cells of the coronary vasculature. The endocardium generates the precursor cells that form coronary plexuses and develop into endothelial cells of coronary arteries, arterioles, and capillaries. Such angiogenic functions of endocardial cells appear evolutionarily conserved, as revealed in transplantation studies in which avian endocardial cells are capable of generating coronary arterial network. Our results show that ventricular endocardial cells are not terminally differentiated but instead are angiogenic for coronary arteries. The angiogenic sprouting and migration of endocardial cells into the myocardium is induced by myocardial Vegf-a to endocardial Vegfr-2 signaling. This is consistent with previous morphological analysis suggesting that the earliest vessels develop when encasing endocardial cells penetrate the myocardium and proliferate into an interconnected coronary network (Virá gh and Challice, 1981). In contrast to the requirement for myocardial Vegf-a to endocardial Vegfr2 signaling, neither endocardial deletion of Vegf-a nor proepicardial/epicardial deletion of Vegfr-2 blocked intramyocardial coronary angiogenesis (Z.Z. and B.Z., unpublished data). A hypoxia-dependent Vegf-a concentration gradient exists in the myocardium of the developing heart (Wikenheiser et al., 2006) , and our results indicate that this gradient provides a cue through Vegfr-2 in the endocardium to trigger migration of angiogenic precursor cells from the endocardium into the myocardium ( Figure 7A ). Once in the myocardium, these cells predominantly differentiate into arterial endothelial cells and populate intramyocardial arteries, arterioles, and capillaries.
Our analysis showed that Nfatc1 transcription occurs in the endocardium, but not in the descendant endothelial cells of coronary vessels. Thus, although the Nfatc1 promoter is first active in the endocardial cells, it is then shut off as those cells develop into endothelial cells of the coronary plexuses. Previous studies have found that spatiotemporally regulated Nfatc1 expression maintains progenitor cell status and that its downregulation promotes the differentiation of progenitor cells in the developing heart valves (Wu et al., 2011) or hair follicles (Horsley et al., 2008) . Whether Nfatc1 expression in ventricular endocardial cells maintains their progenitor status and/or primes them for later angiogenesis, and whether scheduled Nfatc1 shut down has a role in coronary angiogenesis are some of important questions currently under investigation.
Though the endocardium is the source of most arterial endothelial cells, the endocardium provides a lesser contribution to coronary veins. Therefore, the coronary veins have their major origin outside the endocardium and arise by a different mechanism than the arterial cells. Previous fate mapping using an inducible Cre (VE-cadherin-CreERT2) (Monvoisin et al., 2006) showed that the vast majority of the endothelial cells in the coronary veins arise during development by E9.5 from the sinus venosus (Red-Horse et al., 2010) . A small number of coronary venous endothelial descendants became coronary artery endothelial cells. Though this led to the conclusion that venous endothelial cells are reprogrammed into arterial endothelial cells, the fraction of coronary arterial endothelial cells arising from the sinus venosus was far less than the fraction of coronary venous endothelial cells. Additionally, a recent study using Scx and Sema3D Cre lines suggested that a subset of proepicardial/ epicardial cells expressing these genes at E9.5 is able to differentiate into multiple cardiovascular cells, mostly epicardial cells and/or fibroblasts as well as a small fractions of coronary endothelial and smooth muscle cells (Katz et al., 2012) . Our fatemapping experiments also showed that a fraction of the sinus venous endothelial cells are derived from the endocardium, suggesting that endocardial cells may contribute to a minor fraction of the coronary venous endothelium via the sinus venosus route.
Collectively, these results suggest a mechanism for coronary vessel development in which the arterial and venous portions mainly arise from largely distinct embryonic endothelial cell populations at different anatomical sites and during distinct developmental windows. Our results showed that around E11.5, endocardial precursor cells, through Vegfr-2, respond to Vegf-a signaling from the myocardium and migrate into the myocardium to form coronary plexuses where they mature into arteries, arterioles, and capillaries. In contrast, the coronary venous endothelial cells arise mostly from sinus venous endothelial cells before E9.5 (Red-Horse et al., 2010) . We propose that these processes act in parallel to form the arterial and venous endothelial populations of the complete coronary vasculature.
Given the importance of coronary artery disease, generation of coronary arteries by tissue engineering is obviously a highly desirable goal. Regenerative approaches that recapitulate normal development may represent an especially attractive path for development of such therapies. Our results imply that programmed transient Nfatc1 expression couple with sustained Vegfr-2-dependent Vegf-a signaling in the progenitor cells of coronary arterial endothelium might be useful strategy for regenerating coronary arteries.
EXPERIMENTAL PROCEDURES Animals
To generate the Nfatc1
Cre mice, an IRES-Cre/PGK-hygromycin cassette was inserted at the 3 0 untranslated region of Nfatc1. To disrupt Vegf-a in the myocardium, Tnnt2 Cre mice (Chen et al., 2006; Jiao et al., 2003) were mated to Vegf-a f/f mice (Gerber et al., 1999 
Immunostainings and RNA In Situ Hybridization
Primary and secondary antibodies used in this study are listed in Table S1 . For immunostainings, mouse embryos from E9.5 to E12.5 or hearts from E13.5 to E16.5 were fixed in 4% paraformaldehyde (PFA). A 15%-30% sucrose gradient was applied to those for frozen sections. Immunohistochemistry was carried out using the ABC-HRP or ABC-AK method (Vector Laboratories). Fluorescent avidin kit (Vector Laboratories) was used for immunofluorescence visualization. Whole-mount or section RNA in situ hybridization was performed to detect Nfatc1 or Cre transcripts in E9.5-E15.5 embryos or hearts using probes for Nfatc1 or Cre mRNA.
Whole-Mount X-Gal Staining Embryos from E9.5 to E12.5 or hearts isolated at E13.5 to E14.5 were fixed in 4% PFA on ice for 30 min to 2 hr depending on the developmental stage, washed in PBS, and then stained with freshly prepared X-gal solution for 2 hr at 37 C or overnight at room temperature. The stained samples were washed by PBS, sectioned, and photographed.
Mouse Ventricular Explant Culture and Coronary Angiogenesis Assay Ventricles without the atria and sinus venosus were isolated from E10.5 or E11.5 embryos, rinsed with PBS to remove circulating cells, and placed in the Matrigel (growth factor reduced, BD Biosciences) in Nunc 4-well plates. The Matrigel was prepared by addition of an equal volume of M199 medium plus 10% fetal bovine serum (FBS) with or without a testing growth factor including Vegf120, 164, 189, Vegf-c, Vegf-d, Fgf2, or Fgf9 (R&D Systems). The final concentration of each growth factor was 10 ng/ml. Explants were cultured for 6 days and angiogenesis by the ventricular endocardial cells was photographed.
Dye Tracing of Ventricular Endocardial Cells in Ventricular Explant Cultures E11.5 hearts were microinjected with the Red Fluorescent CMTPX (CellTracker, Invitrogen) through their ventricles. After a 2 min incubation on ice, atria and sinuses were removed. Ventricles were then rinsed with PBS and placed in the Matrigel with Vegf120. The transmural migration of the labeled individual endocardial cells and their integration into an endothelial network were photographed.
Quail-to-Chick Transplantation Assays
Quail ventricular endocardium or ventricular apex without the epicardium were isolated from the Hamburger and Hamilton stages (HH) 15/16 quail embryos, labeled with carbon particles for visualization, and implanted at the inner curvature of the atrioventricular junction of HH15/16 chick embryonic hearts. The implanted chick embryos were incubated at 37 C until HH34 or HH42.
The chimerical hearts were isolated and fixed with 3.7% formaldehyde and cut into anterior and posterior halves through the right ventricle to expose intramyocardial vasculature, followed by incubation with a mouse monoclonal anti-QH1 antibody to visualize the contribution of quail endocardial cells to the developing chick coronary vasculature.
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